Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GPCPD1 pseudogene 1 (GPCPD1P1) is a pseudogene and does not encode a functional protein. It is classified as a non-coding sequence that is similar in sequence to the protein-coding gene Glycerophosphocholine phosphodiesterase 1 (GPCPD1), but does not itself produce a protein product. There is no evidence for it acting as a molecular target, receptor, enzyme, or having a direct biological function or disease association. GPCPD1P1 is not the same as GPCPD1 (Glycerophosphocholine phosphodiesterase 1), which is a well-characterized enzyme with roles in choline metabolism and cancer biology. The pseudogene GPCPD1P1 is a non-coding genomic region, often annotated during gene mapping, but it is not transcribed into a functional protein and is not considered a therapeutic target. No validated functions, disease associations, interacting drugs, or biomarker roles are reported for GPCPD1P1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GPCPD1 pseudogene 1 (GPCPD1P1).